Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 406 to 420 of 888 results for community guidance

  1. Medical technologies evaluation programme process guide (PMG34)

    This process guide describes how NICE selects medical technologies for development of NICE guidance. It also describes how the medical technologies advisory committee develops guidance on selected technologies routed to it

  2. NICE decision aid: process guide (PMG42)

    This process guide provides an overview of the key principles used for developing NICE decision aids. It ensures that robust, quality-assured decision aids for people using and providing health and social care services are developed in an open, transparent and timely way, with appropriate input from key groups

  3. How effective and cost effective are different types of exercise referral scheme? Compare the relative effects of different models in controlled studies. Include health-related quality of life as an outcome. Compare exercise referral schemes that vary by: - setting – for example, home-based, gym-based, community-based or outdoors - intensity and duration – for example, a 12-week scheme involving 1 session a week, or a 6-week scheme involving 4 1-hour sessions per week - the techniques used, for example, some use additional 'supportive' techniques such as 'motivational interviewing' and education sessions - the target group, for example, people who are overweight and obese, people with raised blood pressure or cholesterol levels or those experiencing mild depression, anxiety or stress; or by age, gender, race or socioeconomic status - other scheme characteristics including: design, content and delivery; referral mechanisms; choice of activity; cost and qualifications of instructors; and whether it is commissioned and delivered by an NHS, non-NHS or community-based organisation.

    schemes that vary by: - setting – for example, home-based, gym-based, community-based or outdoors - intensity and duration – for...

    Research recommendation
    Published
    9 June 2015

  4. GaitSmart rehabilitation exercise programme for gait and mobility issues (HTG716)

    Evidence-based recommendations on GaitSmart rehabilitation exercise programme for gait and mobility issues in adults.

    HealthTech guidance
    Published
    3 April 2024
    View recommendations

    Sections for HTG716

  5. Step-by-step guide to registering as a stakeholder

    How to register as a stakeholder with NICE.

  6. Step-by-step guide to registering as a stakeholder

    How to register as a stakeholder with NICE.

  7. What is the most effective way to monitor and evaluate community-wide approaches to obesity to ensure: 1) evidence of effectiveness is gathered across the breadth of the local system and 2) data are produced to help local communities adapt and improve their approach?

    Question What is the most effective way to monitor and evaluate community-wide approaches to obesity to ensure: 1) evidence of...

    Research recommendation
    Published
    9 June 2015

  8. Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)

    This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.

    Clinical guideline
    Last updated
    26 April 2023
    View recommendations

    Sections for CG104

  9. The Juxta CURES adjustable compression system for treating venous leg ulcers (MIB25)

    NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers

    Medtech innovation briefing
    Published
    25 March 2015

  10. Cystic fibrosis: diagnosis and management (NG78)

    This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.

    NICE guideline
    Published
    25 October 2017
    View recommendations

    Sections for NG78

  11. Geriatric assessment and care:- What is the cost-effectiveness of comprehensive geriatric assessment and care on specialist units compared with alternative models of care on general wards?

    include the use of health and social care resources (including in the community and care homes) as well as unpaid care.Data are needed...

    Research recommendation
    Published
    29 January 2016

  12. Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the community predict neutropenic sepsis and the outcomes of these episodes.

    sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the...

    Research recommendation
    Published
    9 June 2015

  13. Standard principles of infection prevention and control:- What are the barriers to compliance with the standard principles of infection prevention and control that patients and carers experience in their own homes?

    No evidence of surveillance of healthcare-associated infections in the community is currently available in the UK. A qualitative study...

    Research recommendation
    Published
    9 June 2015

  14. Prevalence and natural history of non-IgE-mediated food allergy:- How common are non-IgE-mediated food allergies in children and young people in primary care and community settings and when food allergies may be outgrown?

    non-IgE-mediated food allergies in children and young people in primary care and community settings and when food allergies may be...

    Research recommendation
    Published
    9 June 2015

  15. Indicator advisory committee members

    Read biographies for all members of NICE's indicator advisory committee.